About Cadrenal Therapeutics, Inc. 
Cadrenal Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (3.61%)
Foreign Institutions
Held by 3 Foreign Institutions (0.08%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
Pharmaceuticals & Biotechnology
USD 27 Million ()
NA (Loss Making)
NA
0.00%
-1.30
-328.17%
6.37






